Antiphospholipid antibodies in patients with dysglycaemia: A neglected cardiovascular risk factor?
{{output}}
Background: Cardiovascular disease is a serious complication in patients with dysglycaemia, defined as either type 2 diabetes or impaired glucose tolerance. Research focusing on the identification of potential markers for atherot... ...
